You may have heard about MTHFR in the context of pregnancy, cardiovascular disease, or mental health — but the full scope of what this gene variant affects is far broader than most patients are told.
MTHFR is one of the most clinically significant genetic variants in functional medicine. It affects a biochemical process called methylation that is involved in virtually every major physiological system in the body. Understanding your MTHFR status — and knowing what to do about it — can explain years of unexplained symptoms and open a clear path toward targeted, effective treatment.
What Is Methylation?
Methylation is the process of adding a methyl group (one carbon atom bonded to three hydrogen atoms: CH?) to a molecule. This may sound biochemically obscure, but methylation is one of the most fundamental reactions in human physiology. It occurs over a billion times per second in every cell of your body.
Methylation is required for:
- Neurotransmitter synthesis and regulation — production of serotonin, dopamine, norepinephrine, and melatonin; breakdown of excess catecholamines
- DNA synthesis and repair — methylation of DNA bases is essential for gene expression regulation and protection against mutations
- Detoxification — Phase II liver detoxification relies heavily on methylation to neutralize toxins, hormones, and heavy metals
- Homocysteine metabolism — remethylation of homocysteine (an inflammatory amino acid) back to methionine requires the MTHFR enzyme
- Immune function — T-cell and B-cell differentiation, inflammatory cytokine regulation
- Energy production — mitochondrial function and CoQ10 synthesis
- Myelin synthesis — the insulating sheath around nerve fibers depends on adequate methylation
- Histamine breakdown — methylation degrades histamine; impaired methylation can contribute to histamine intolerance
The central hub of methylation is the methionine cycle, fueled primarily by folate (vitamin B9) and vitamin B12. The MTHFR enzyme is the critical rate-limiting step in this cycle.
What Is the MTHFR Gene?
MTHFR stands for methylenetetrahydrofolate reductase — the enzyme encoded by the MTHFR gene that converts dietary folate into its active, usable form: 5-methyltetrahydrofolate (5-MTHF).
5-MTHF is the form of folate that donates methyl groups throughout the methylation cycle. Without adequate 5-MTHF, the entire methylation system slows — reducing neurotransmitter production, impairing detoxification, and allowing homocysteine to accumulate.
The Two Key MTHFR Variants
C677T
The C677T variant is the most clinically significant MTHFR polymorphism. It occurs at position 677 of the gene, where cytosine (C) is substituted for thymine (T).
- Heterozygous (one copy: CT): Approximately 40% of the general population. Reduces MTHFR enzyme activity by approximately 35%.
- Homozygous (two copies: TT): Approximately 10–15% of the population. Reduces MTHFR enzyme activity by approximately 70%.
The homozygous C677T variant is strongly associated with elevated homocysteine, reduced folate conversion, and increased risk across a range of conditions.
A1298C
The A1298C variant occurs at position 1298 and has a somewhat different functional effect — primarily affecting the production of BH4 (tetrahydrobiopterin), a critical cofactor for serotonin, dopamine, and nitric oxide synthesis.
- The A1298C variant is often associated more with neurological and mood symptoms than with elevated homocysteine
- Compound heterozygosity — carrying one C677T and one A1298C variant — is common and produces more significant methylation impairment than either variant alone
Health Conditions Associated With MTHFR Variants
The clinical implications of impaired methylation span multiple body systems:
Cardiovascular Disease
The strongest and most replicated clinical association of MTHFR variants is with elevated homocysteine. Homocysteine is a pro-inflammatory amino acid that damages arterial walls, promotes oxidative stress, activates clotting pathways, and is an independent risk factor for heart attack, stroke, and peripheral vascular disease.
When MTHFR function is impaired, homocysteine is not adequately remethylated back to methionine — it accumulates. Elevated homocysteine is a direct cardiovascular risk marker that is entirely modifiable with appropriate B vitamin supplementation.
Neurological and Psychiatric Conditions
Reduced neurotransmitter synthesis from impaired methylation is associated with:
- Depression — reduced serotonin and dopamine production
- Anxiety — reduced GABA synthesis and elevated stress catecholamines
- Bipolar disorder and schizophrenia — multiple studies show higher MTHFR variant prevalence
- ADHD — dopamine dysregulation from impaired methylation
- Autism spectrum disorder — methylation impairment affects neurodevelopment
- Dementia and cognitive decline — homocysteine is independently neurotoxic; elevated homocysteine significantly increases Alzheimer’s risk
Pregnancy Complications
The relationship between MTHFR and pregnancy outcomes is well-established. Impaired folate metabolism from MTHFR variants is associated with neural tube defects (spina bifida, anencephaly), recurrent miscarriage, placental abruption, preeclampsia, and preterm birth. This is why women with MTHFR variants require methylated folate (5-MTHF) rather than synthetic folic acid — which MTHFR-impaired individuals cannot adequately convert.
Chronic Fatigue and Fibromyalgia
Mitochondrial impairment from reduced methylation capacity, combined with impaired neurotransmitter production and detoxification, creates the conditions for the fatigue, pain, and cognitive symptoms of fibromyalgia and chronic fatigue syndrome. MTHFR variants are significantly overrepresented in these populations.
Hormonal Imbalances
Methylation is required for estrogen detoxification — converting active estrogens to inactive metabolites for excretion. Impaired methylation can contribute to estrogen dominance, a hormonal imbalance associated with PMS, endometriosis, fibrocystic breasts, and increased breast cancer risk.
Chemical Sensitivity and Toxin Accumulation
Impaired methylation reduces detoxification capacity, making individuals more susceptible to the effects of heavy metals, pesticides, and other environmental toxins that require methylation for clearance.
Why Folic Acid Is the Wrong Answer for MTHFR
This is one of the most clinically important points in MTHFR management: standard folic acid — the synthetic form added to processed foods and found in most multivitamins — must be converted by the MTHFR enzyme to be usable.
For individuals with significant MTHFR variants, this conversion is severely impaired. Unmetabolized folic acid can actually accumulate in the bloodstream, potentially blocking folate receptors and worsening the functional folate deficiency.
The correct supplementation is methylfolate (5-MTHF) — the pre-converted, biologically active form that bypasses the MTHFR conversion step entirely. Similarly, methylcobalamin (the active form of B12) is preferred over cyanocobalamin or hydroxocobalamin for individuals with impaired methylation.
The COMT Connection
MTHFR rarely operates in isolation. In Dr. Veselak’s clinical practice, genetic assessment routinely evaluates COMT alongside MTHFR — because the two variants interact in ways that significantly affect the clinical picture.
COMT (catechol-O-methyltransferase) encodes the enzyme that breaks down dopamine, epinephrine, and estrogen in the prefrontal cortex. COMT requires SAMe — the primary methyl donor produced by the methylation cycle — to function.
When MTHFR impairs methylation, SAMe production declines. This reduces COMT activity, causing dopamine and epinephrine to accumulate — producing anxiety, pain sensitivity, and emotional reactivity. Meanwhile, impaired estrogen breakdown from reduced COMT activity compounds hormonal imbalances.
Understanding the MTHFR-COMT interaction allows treatment to be precisely targeted to the patient’s specific genetic pattern.
Testing and Treatment
Testing
MTHFR genotyping is available through a simple blood or saliva test. Dr. Veselak evaluates MTHFR in the context of a broader genetic and functional assessment including COMT, COMT, CBS (cystathionine beta-synthase), and other methylation pathway variants — as well as functional markers including homocysteine, methylmalonic acid, and SAMe levels that reveal how methylation is actually performing.
Treatment Protocol
Treatment is individualized based on variant type, functional markers, and clinical symptoms:
Methylfolate (5-MTHF): The cornerstone of MTHFR support. Dosing is individualized — some patients with significant variants require therapeutic doses; others respond better to lower doses, particularly when COMT variants are co-present (high-dose methylfolate can overstimulate COMT-variant individuals).
Methylcobalamin (B12): Works synergistically with methylfolate in the methylation cycle. Essential for homocysteine management and neurological function.
Riboflavin (B2): The MTHFR enzyme requires riboflavin as a cofactor. Riboflavin supplementation can partially compensate for reduced MTHFR enzyme activity, particularly in C677T homozygous individuals.
Betaine (TMG): Provides an alternative methylation pathway (the BHMT pathway) that can bypass impaired MTHFR function for homocysteine remethylation.
Magnesium: Required at multiple points in the methylation cycle and frequently deficient in MTHFR-variant individuals.
Dietary optimization: Emphasizing natural food folates (leafy greens, legumes, eggs) and reducing or eliminating synthetic folic acid from fortified foods and supplements.
Frequently Asked Questions
If I have an MTHFR variant, does that mean I’ll develop these conditions?
No. MTHFR variants are risk factors, not deterministic. Many people with significant MTHFR variants live without major health issues — particularly those with excellent diet, low toxic burden, and good lifestyle habits. Identifying the variant allows for targeted preventive intervention.
Should I get tested even if I feel healthy?
If you have a family history of cardiovascular disease, depression, miscarriage, autism, or other MTHFR-associated conditions — or if you are planning pregnancy — testing is valuable. Prevention is always easier than treatment.
Can children have MTHFR issues?
Yes. MTHFR variants are present from birth. In children, they may manifest as developmental delays, ADHD, anxiety, recurrent infections, or other neurological and immune challenges.
Is methylfolate safe to take without testing?
Methylfolate is safe for most people, but individuals with COMT variants may experience overstimulation from high doses. Testing before supplementing allows dosing to be precisely calibrated to your genetic profile.
Your Genes Are Not Your Destiny — But They Are Your Roadmap
MTHFR variants do not condemn you to poor health. They reveal where your physiology is most vulnerable — and where targeted support produces the most significant results. For many patients, understanding their MTHFR status is the piece that finally explains years of unexplained symptoms and points directly toward effective treatment.
Dr. Veselak’s functional medicine practice in Camarillo, CA provides comprehensive genetic assessment and personalized methylation support for patients throughout Ventura County, Los Angeles, and Southern California.
Contact our office to schedule your consultation.
Related Reading
- Functional Medicine: Root-Cause Healthcare in Camarillo CA — our complete guide
- Functional Medicine Lab Testing: What We Look For and Why Standard Tests Miss It
- Functional Medicine for Autoimmune Conditions
Related Articles
Explore these articles on genetics, methylation, and mental health:
Leave a Reply